Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Specific Protection of Folate Reductase Against Chemical and Proteolytic Inactivation

MAIRE T. HAKALA and ELSE-MAJ SUOLINNA
Molecular Pharmacology September 1966, 2 (5) 465-480;
MAIRE T. HAKALA
Department of Experimental Therapeutics, Roswell Park Memorial Institute, Buffalo, New York 14203
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELSE-MAJ SUOLINNA
Department of Experimental Therapeutics, Roswell Park Memorial Institute, Buffalo, New York 14203
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Folate reductase of amethopterin resistant S-180 cells (AT/3000), grown in vitro, is inactivated by o-phenanthroline, EDTA, p-chloromercuribenzoate, iodoacetamide, trypsin, subtilisin, elastase, and carboxypeptidase B, but not by carboxypeptidase-A or leucineaminopeptidase. The enzymatic activity and the number of amethopterin binding sites were always lost in parallel fashion. When substrates or coenzymes were present, complete protection of the enzymic activity and of the amethopterin binding sites against all these agents was observed. Competitive inhibitors, 2,4-diaminopurine and -pyrimidine, which mimic just a small portion of the substrate molecule, also protected completely against o-phenanthroline and against the proteolytic enzymes but poorly against SH-reagents. It is suggested that folate (probably the pyrimidine portion of it) and TPNH are bound to the enzyme in the proximity of a metal and SH-groups. The protection against the proteolytic digestions is probably provided through conformational changes in the enzyme. No major proteolytic breakdown of the enzyme molecule, as a whole, was observed when folate reductase was complexed with amethopterin.

It is suggested that the intracellular presence of substrate, coenzyme or competitive inhibitor of folate reductase may alter the turnover of this enzyme by preventing the proteolytic breakdown. In certain circumstances this could lead to an increase in the folate reductase content of cells and tissues. Also, it is concluded that folate reductase can form binary complexes with both the substrate and the coenzyme. Thus, the prior presence of coenzyme on the enzyme surface is not necessary for the attachment of the substrate and vice versa. Since the concentrations of folate, TPNH, and TPN which afforded 50% protection were of the same order of magnitude as the respective Km values, it seems that the presence of one on the enzyme surface does not affect the affinity to the other.

ACKNOWLEDGMENTS The authors wish to express their appreciation to Mrs. L. Kenny and Miss D. Sugg for their skillful technical assistance. This investigation was supported in part by research grant CA-04175 from the National Cancer Institute of the U.S. Public Health Service.

  • Copyright ©, 1966, by Academic Press Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 2, Issue 5
1 Sep 1966
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Specific Protection of Folate Reductase Against Chemical and Proteolytic Inactivation
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Specific Protection of Folate Reductase Against Chemical and Proteolytic Inactivation

MAIRE T. HAKALA and ELSE-MAJ SUOLINNA
Molecular Pharmacology September 1, 1966, 2 (5) 465-480;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Specific Protection of Folate Reductase Against Chemical and Proteolytic Inactivation

MAIRE T. HAKALA and ELSE-MAJ SUOLINNA
Molecular Pharmacology September 1, 1966, 2 (5) 465-480;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
  • Benzbromarone Relaxes Airway Smooth Muscle via BK Activation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics